Consulting Services

Regulatory Affairs Consulting

Strategic FDA regulatory affairs support for pharmaceutical, biotech, and medical device companies, from IND and NDA strategy through submission, approval, and post-market compliance.

IND Applications NDA / BLA / ANDA FDA Strategy CMC Regulatory Post-Market Compliance

Navigating the FDA Regulatory Landscape with Confidence

The regulatory pathway from development through approval demands precise strategy, deep regulatory knowledge, and meticulous documentation. GxP Global Quality Network provides expert regulatory affairs consulting to guide your product through every stage of the FDA regulatory process.

From early-phase IND strategy to NDA/BLA submission management, post-approval changes, and ongoing regulatory compliance, we serve as a trusted senior regulatory partner, helping you move critical programs forward with speed and confidence.

Regulatory Affairs Services

FDA regulatory strategy development and pathway assessment
IND application preparation, submission, and lifecycle management
NDA, BLA, and ANDA preparation and submission support
CMC regulatory support: drug substance and drug product documentation
FDA meeting preparation and agency communication strategy
Annual report preparation and regulatory filing management
Post-approval supplement and variation management (PAS, CBE-30, CBE-0)
Labeling review, revision, and regulatory compliance assessment
Regulatory due diligence for business development and M&A

Regulatory Intelligence & Gap Analysis

Regulatory gap assessments against current FDA guidance documents
Guidance document tracking and impact analysis
Competitive intelligence and regulatory landscape analysis
Warning letter and 483 response strategy and preparation
Consent decree compliance support

Our Approach

Engagements combine strategic regulatory expertise with practical operational support, ensuring your submissions are scientifically sound, regulatory defensible, and delivered on time. Network consultants work as an integrated extension of your regulatory team, bringing senior-level insight to every project.

Quality standard: All GxP Global Quality Network engagements are led by senior-credentialed auditors with 20+ years of active GxP audit experience, regulatory currency across FDA, EMA, MHRA, and Health Canada standards, and direct accountability for every deliverable.